BeOne Medicines (ONC) Tax Rate (2015 - 2026)
BeOne Medicines' (ONC) quarterly Tax Rate came in at 12.29% in Q1 2026, down 8163.0% year-on-year from 0.15% in Q1 2025, and down 77.83% on a QoQ basis from 55.44% in Q4 2025.
BeOne Medicines (ONC) Tax Rate (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has 12 years of Tax Rate data on file, last reported at 12.29% in Q1 2026.
- On a quarterly basis, Tax Rate fell 8163.0% year-over-year to 12.29% in Q1 2026; TTM through Mar 2026 was 21.7%, a 6773.0% increase from a year earlier, with the FY2025 full-year figure at 31.17%, up 5214.0% from the prior year.
- Tax Rate for Q1 2026 stood at 12.29%, down from 55.44% in the prior quarter.
- Over the last five years, Tax Rate for ONC reached as high as 93.92% in Q1 2025 and fell as low as 77.95% in Q4 2024.
- Historically, Tax Rate has averaged 2.87% across 5 years, with a median of 3.17% in 2024.
- Across the five-year window, Tax Rate surged 13339 bps in 2025 and tumbled 8163 bps in 2026, its largest moves.
- Year by year, Tax Rate stood at 3.33% in 2022, then slumped by 43 bps to 4.78% in 2023, then sank by 1529 bps to 77.95% in 2024, then surged by 171 bps to 55.44% in 2025, then sank by 78 bps to 12.29% in 2026.
- Per Business Quant data, the three most recent Tax Rate figures were 12.29% in Q1 2026, 55.44% in Q4 2025, and 15.17% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.34 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 5.61 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.29 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.68 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.51 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -13.70 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 7.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.29 |
| Mar 31, 2026 | 12.29 |
| Mar 31, 2026 | 12.29 |
| Dec 31, 2025 | 55.44 |
| Dec 31, 2025 | 55.44 |
| Dec 31, 2025 | 55.44 |
| Sep 30, 2025 | 15.17 |
| Sep 30, 2025 | 15.17 |
| Sep 30, 2025 | 15.17 |
| Jun 30, 2025 | 5.25 |
| Jun 30, 2025 | 5.25 |
| Jun 30, 2025 | 5.25 |
| Mar 31, 2025 | 93.92 |
| Mar 31, 2025 | 93.92 |
| Mar 31, 2025 | 93.92 |
| Dec 31, 2024 | -77.95 |
| Dec 31, 2024 | -77.95 |
| Dec 31, 2024 | -77.95 |
| Sep 30, 2024 | -23.44 |
| Sep 30, 2024 | -23.44 |